As both kind of diabetes continues to be prevalent among the world’s population, the same goes for experts when it comes to developing ways to manage the disease or maybe even cure it for good. Recently, it was reported that an Ayurvedic supplement can help reduce the blood sugar levels in a person who suffers from type 2 diabetes.
Like with any disease or condition, there are people who prefer taking a more natural approach to treat it or manage it better compared to using prescription medication. Express reports that this certain Ayurvedic supplement was proven to be able to lower the blood sugar levels in a person, which could be beneficial for those suffering from type 2 diabetes. To be specific, the Gymnema supplements.
Gymnema is short for Gymnema Sylvestre, which is a herb that is used in treating or managing diabetes through an Ayurvedic means. Ayurvedic refers to the type of treatment that stems from India. This herb is referred to as “gumar,” in Hindu, which translates to “sugar destroyer,” an appropriate name for its purpose.
This was proven in a study, where patients who suffer from type 2 diabetes took 400mg of Gymnema leaf extract every day for a period of 18 to 20 months. Within the time frame, it was revealed that the participants’ blood sugar levels have lowered by up to 29 percent.
Further research could also prove that this supplement can also be beneficial for those with type 1 diabetes. This is because it helps suppress cravings for sweets through the sweet-taste sensation in the mouth. According to experts, Gymnema works by reducing the gut’s ability to absorb sugar, and therefore promote the uptake of sugar from the blood at a cellular level. For type 1 diabetes, it can also help in the production of insulin from the pancreas.
This type of treatment is becoming more and more popular in the West, as many people have begun to resort to this method when it comes to managing or curing their conditions. When it comes to type 2 diabetes, in order for this method to work, major changes in lifestyle such as diet and exercise should be done as well, to lower blood sugar levels.


The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
3 clinical-grade skincare creams you really shouldn’t buy online
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



